Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Incyte
Pharma
Incyte to seek FDA approval for Monjuvi in front-line DLBCL
Even if Monjuvi got its FDA approval in first-line DLBCL, analysts at William Blair said they “remain cautious on ultimate market share.”
Angus Liu
Jan 5, 2026 10:40am
Incyte taps Winnie Harlow to model vitiligo awareness
Dec 2, 2025 12:05pm
Incyte expands awards program to hidradenitis suppurativa
Nov 6, 2025 10:00am
Incyte sheds light on life with HS in new HCP campaign
Sep 3, 2025 3:37pm
New Incyte CEO takes 'fresh look' at business, outlines BD plan
Aug 4, 2025 11:16am
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Jul 18, 2025 9:04am
